Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Increased risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients has been attributed to long-standing chronic inflammation, with the contribution of genetic alterations and environmental factors such as the microbiota. Moreover, accumulating data indicate that IBD-associated CR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucafò, Marianna, Curci, Debora, Franzin, Martina, Decorti, Giuliana, Stocco, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563785/
https://www.ncbi.nlm.nih.gov/pubmed/34744751
http://dx.doi.org/10.3389/fphar.2021.772101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563785/
https://www.ncbi.nlm.nih.gov/pubmed/34744751
http://dx.doi.org/10.3389/fphar.2021.772101

Ejemplares similares